Notably, partial anti-PD-L1 antibodies caused apoptosis of PD-L1+ T-cells, even PD-1-knockout T-cells, by activating p38 MAPK, and that such antibodies failed to suppress B16-OVA and RENCA tumor growth in vivo (77). Here, CD274 is linked to neoplasm.